AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Rituxan (Genentech) (rituxan.com)
This is a high-integrity, substance-heavy pharmaceutical website that successfully prioritizes clinical accuracy and safety over marketing fluff. It is almost entirely devoid of traditional business bullshit, save for a few minor corporate power-phrases in the top-level headings.
To achieve a near-zero BS score, the site should include direct, clickable outbound links to published clinical trial data on PubMed or ClinicalTrials.gov. Adding a ‘Last Updated’ timestamp to each specific disease page would improve transparency for the 2026 temporal context. Specifically, the homepage H1 could be replaced with a more technical, product-focused headline to match the substance of the sub-pages. Finally, adding Person schema for the Chief Medical Officer or lead researchers would close the institutional authority gap.
Substance density is high, as the text consists largely of mandated clinical disclosures and specific diagnostic indications. While the H1 ‘COMMITTED TO CONNECTING YOU WITH YOUR TREATMENT’ is a standard corporate power-phrase, it is anchored by high-density technical data regarding Rheumatoid Arthritis (RA) and Pemphigus Vulgaris (PV). The ratio of specific nouns (e.g., ‘intravenous infusion’, ‘B-cell acute leukemia’) to fluff is highly favorable.
Breadcrumbs, clusters, and parent child paths must exist in the HTML — not just in schema. Start your free link graph inspection and see whether your hierarchy survives a machine level crawl.
There is no detectable semantic drift between the homepage signal and sub-page delivery. The homepage promises information for patients regarding six specific medical indications, and the sub-pages for NHL and CLL deliver exact details on treatment response, dosing, and safety for those specific populations. The messaging is consistently clinical and safety-oriented throughout.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
The site does not engage in typical trust theatre like unverified testimonials or award badges. However, it loses minor points because while it references ‘Prescribing Information’ and the ‘Medication Guide,’ the crawled data shows a proof_links_count of 0, indicating a lack of direct outbound links to peer-reviewed clinical study results in the primary text blocks. This is a common but notable proof-path gap.
The proof-to-fluff ratio is excellent. For every claim of being an ‘FDA-approved treatment,’ the site provides a corresponding section on INDICATIONS and possible side effects. The data is highly specific, referencing ages (e.g., ‘children 6 months of age and older’) and specific combination therapies (e.g., ‘with glucocorticoids’).
To examine how structural entropy affects chunking and retrieval, review the Moz Semantic HTML audit. View the Moz Semantic HTML Audit for a complete example of heading logic, landmark integrity, and DOM depth diagnostics.
The site uses specific industry jargon like ‘FDA-approved’ and ‘CD20-positive B-cells’ which are functional rather than cliché. It avoids the value_prop_cliches identified in the dictionary, such as ‘innovation for life.’ The inclusion of a specific financial limit for support (‘$25,000 per calendar year’) further separates the value proposition from generic industry templates.
Authority is solidly established through the Genentech Organization schema and the prominent FDA adverse event reporting instructions. There are no unverifiable expert claims; the site relies on institutional authority rather than individual ‘expert’ personas. The technical implementation of heading hierarchy (H1 to H5) is structurally sound and meaningful.
The site’s marketing tone is exceptionally reserved, fitting for a regulated pharmaceutical product. Bold performance claims are replaced by moderated clinical statements such as ‘is thought to work’ and ‘to reduce the signs and symptoms.’ There is no disconnect between the promise of a medical treatment and the dense technical safety data provided to back it up.
Medical Devices, Pharma & Biotech BS: Rituxan (Genentech) (rituxan.com)
The content perfectly matches the Pharmaceutical and Biotech industry profile. It focuses entirely on a specific therapeutic antibody (rituximab), its mechanism of action on CD20-positive B-cells, and the regulatory indications for serious conditions like NHL and CLL.
When your canonical, redirect, and final URL disagree, the model treats each version as a separate entity. Study the Canonical Integrity Framework Guide and see why stable identity is the prerequisite for AI driven retrieval.
“The score of 13 is one of the lowest possible for a commercial site, driven by high Information Density and zero Semantic Coherence issues. The remaining points are derived from the lack of direct outbound evidence links and the minor presence of generic corporate phrasing in the hero sections.”